Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose. (Q38330358)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Petra Baumgaertner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sébastien Wieckowski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Estelle Devêvre

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Philippe Guillaume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Immanuel Luescher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Nathalie Rufer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Daniel E Speiser

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

12 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

817-826

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22080404%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-011-1140-1

16 January 2020

exact match

0 references

cites work

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

The molecular basis for public T-cell responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Functional signatures of protective antiviral T-cell immunity in human virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

CD8+ T cell efficacy in vaccination and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Shaping and reshaping CD8+ T-cell memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Quantitation of CD8+ T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Maximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

High-avidity CD8+ T cells: optimal soldiers in the war against viruses and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1

Antigen kinetics determines immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1140-1